Latest news with #PCBLChemical
Mint
5 days ago
- Business
- Mint
SBI Cards to Piramal Pharma - Prashanth Tapse suggests 3 stocks to buy in the short term
Stock market today: Indian stocks gained on Friday, recovering from an initial decline, following the Reserve Bank of India's unexpected decision to cut its key repo rate by 50 basis points to bolster economic growth. In a surprise move, the central bank also reduced banks' Cash Reserve Ratio (CRR) by 100 basis points and shifted its policy stance from accommodative to neutral. As of 12:46 IST, the Nifty 50 increased by 0.93% to reach 24,980 . 45, while the Sensex was up by 0.9% at 82,131.45. Prior to the RBI's policy announcement, the indices were down approximately 0.2%. Prashanth Tapse of Mehta Equities believes that Nifty 50 breakout above the 24,900 level could open the door to a new leg higher. Tapse recommends buying SBI Cards, PCBL Chemical, 360 ONE WAM, and Piramal Pharma. Nifty 50 is currently trading at 24,716, showing a mild pullback but still maintaining its overall bullish setup. The index continues to hold key supports at 24,650 and 24,500, which are acting as accumulation zones. Momentum indicators such as RSI remain neutral to positive, and the MACD is close to a bullish crossover. A breakout above the 24,900 level could open the door to a new leg higher. Until then, buying on dips near support is recommended for positional traders. Resistance: 24,800 – 24,900 Bank Nifty is trading at 55,903, up by 154 points, and continues to trend upward within a broad consolidation range. The index has respected its support at 55,700 and 55,500, and momentum remains intact. The RSI reflects steady strength, while the MACD is on the verge of confirming a bullish signal. A close above 56,100 would confirm a breakout and may result in strong momentum-driven gains. Traders may use any intraday dips to build long positions with a defined stop loss. Resistance: 56,000 – 56,100 Prashanth Tapse recommends buying these three stocks in the short term -SBI Cards and Payment Services Ltd, PCBL Chemical Ltd, 360 ONE WAM Ltd, and Piramal Pharma Ltd. SBI Cards share price is maintaining a positive trend after stabilizing near the ₹ 920– ₹ 930 range. The stock is forming a strong base with gradually improving momentum on the daily chart. Technical indicators such as RSI are showing a bullish bias, suggesting increased buying interest. The price is also holding well above short-term moving averages. A move above ₹ 950 could trigger a breakout, opening targets of ₹ 980 and ₹ 1000. Traders may consider initiating fresh longs at current levels with a stop loss at ₹ 918, aligning with a favourable risk-to-reward setup. PCBL Chemical share price is exhibiting early signs of a potential breakout from its consolidation phase. The stock has been trading in a tight range while building higher lows, which is a constructive technical sign. Momentum indicators like RSI are trending higher, and volume has started to rise slightly, hinting at accumulation. The price structure suggests that a move above ₹ 430 could lead to a quick rally toward ₹ 445 and ₹ 460. Traders can consider buying at current levels with a stop loss at ₹ 414 to capture the next directional move. 360 ONE share price has been consolidating within a narrow range after a sharp run-up, indicating strength and readiness for a continuation move. The stock is trading above key moving averages and is supported by a strong RSI and MACD setup. A breakout above ₹ 1,080 could lead to a fresh rally toward ₹ 1,120 and beyond. The consolidation pattern adds reliability to the setup, and the stock looks well-positioned for a short- to medium-term uptrend. Entries near the current level are attractive, with a protective stop loss at ₹ 1,040. PPL Pharma share price has shown a strong rebound from its recent lows and is now trading with a positive bias near ₹ 208. The stock is forming a bullish flag pattern, supported by increasing volumes and an improving RSI trend. Momentum is gradually building, and the MACD is on the verge of a crossover that could add further strength. If the price sustains above ₹ 210, it may witness a swift up move toward ₹ 225 and ₹ 235. Traders looking for fresh opportunities in the pharma sector can consider buying with a stop loss at ₹ 198. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
01-06-2025
- Business
- Mint
From VA Tech Wabag to PCBL Chemical— Devarsh Vakil of HDFC Securities suggests 5 stocks to buy for long term
Stocks to buy for the long term: Indian stock market benchmark, Nifty 50, extended gains to the third consecutive month in May, supported by largely better Q4 earnings, foreign capital inflows and healthy domestic macroeconomic indicators. However, stretched valuations and geopolitical uncertainties kept the gains capped. The Nifty 50 rose nearly 2 per cent in May after a 3 per cent gain in April and a 6 per cent gain in March. Year-to-date, the index has risen 4.7 per cent. Experts point out the remarkable resilience of the Indian economy and markets, which have overcome domestic and global challenges. They remain positive about the domestic market's medium-term prospects due to a healthy economic growth outlook and a strong influx of retail investors. "The medium-term outlook remains bright, supported by robust growth prospects driven by a domestically-oriented economy, youthful demographics, and advancing digitalisation— creating diverse, high-quality investment opportunities across industries," said Devarsh Vakil, Head of Prime Research, HDFC Securities. "India's domestic economic foundation provides protection against global volatility, reinforcing that market downturns are temporary. We maintain a bullish outlook on markets for the long term and present these five long-term investment opportunities," Vakil said. Vakil picks the following five stocks to buy for the next one to two years for healthy upside. Do you own any? PCBL Chemical is India's largest and the world's 7th largest carbon black company, which is essentially used as a reinforcing material for manufacturing tyres. The company has presence in three major product lines: (i) tyres, (ii) performance blacks, and (iii) speciality blacks. Management is positive on the long-term demand outlook. Management hinted that the completion of de-stocking in the global market and lowering inflation could be positive for demand pickup. The company will continue to operate in capex mode for the next three years, adding brownfield capacity in Chennai, doubling aqua-pharm capacity, increasing speciality CB capacity, and infusing money into the JV to capture future growth opportunities. The company has started work on a large-scale pilot plant in India that will develop nano-silicon additives for use in the anodes of Li-Ion batteries. It is looking to invest nearly $30 million in the JV and expects combined JV EBITDA of ₹ 800-900 crore at peak levels in the 36 months after commercialisation. It expects commercialisation by Q4FY27E. "We expect revenue and PAT to increase at a CAGR of nearly 14 per cent and 20 per cent, respectively, over FY25-27E. At the current market price, the stock trades at 21.5 times FY27E EPS (earnings per share)," said Vakil. Va Tech Wabag is a pure-play water company with a strong presence of more than 25 years in water technology and customised water treatment solutions through EPC (engineering, procurement, and construction) services, O&M (operations and maintenance) services, research and development, construction and commissioning. The company exhibits multiple growth triggers, with record FY25 performance across key metrics like sales, EBITDA, PAT, healthy cash balance, and order book (three times sales), ensuring strong revenue predictability for three years. Wabag's asset-light, profitable growth strategy, 95 per cent multilateral/sovereign-backed order book, expanding international focus, along with an upgraded AA credit rating, exhibits robust investment potential. "Investors can buy the stock at current levels for a target price of ₹ 2,100 per share (33 times FY26E EPS)," said Vakil. Star Cement is one of the leading players in the most profitable North-East region. With a cement capacity of 7.7 MTPA, Star commands a nearly 24 per cent share in the North-East market. "We believe that it has a strong, sustainable competitive advantage in the North East region, as entry of outside players in this market is limited," Vakil said. Over the years, Star has created a strong brand recall and is well-positioned to capitalise on future growth opportunities. "We expect a healthy performance from the company in the coming years on the back of increased clinker and cement capacity, leadership position in the profitable and growing North-East market, and cost-saving initiatives to drive profitability," said Vakil. "We believe investors can buy the stock in ₹ 210-225 band (10.9 times FY27E EV/EBITDA) and add on dips in ₹ 180-195 (9.4 times FY27E EV/EBITDA) band - fair value of ₹ 260 (12.8 times FY27E EV/EBITDA) over the next two to three quarters," said Vakil. EPL is the leading manufacturer of laminated plastic tubes in the world, with nearly 35 per cent market share in oral care and catering to companies like Unilever, Colgate, P&G, etc. In the personal care market, EPL's global share stands at nearly 10 per cent, and with an opportunity three times as big as oral care, the runway for growth is long. EPL is a market leader (nearly 20 times share in global speciality packaging) that is set to continue gaining market share in an industry which is undergoing a structural shift owing to innovative product introduction. EPL's strong innovation pipeline, a plethora of sustainable solutions, is expected to be quickly adopted by larger personal care brands given their commitment to sustainability goals. The company has delivered robust results in recent quarters amidst a challenging geopolitical backdrop. The key positive is the sustained margin expansion, as the EBITDA margin expanded for the 10th consecutive quarter. EPL's management has committed to delivering double-digit revenue growth and with an EBITDA margin ambition of nearly 20 per cent in FY26. Stability in raw material prices should further aid the margin recovery. "Going ahead, we expect revenue and EBITDA CAGR of 10 per cent and 14 per cent, respectively, over FY25-27E. RoCE and RoE are expected to increase further from 16.3 per cent and 17.4 per cent, respectively, in FY25 to 17.9 per cent and 21.1 per cent by FY27. The company currently trades at 15.5 times FY27E EPS," said Vakil. Castrol India is an automotive and industrial lubricant manufacturing company, supported by a strong distribution network that reaches over 1.48 lakh retail outlets and 350 distributors. Castrol India is focused on brand building, widening the distribution network, and launching new products, which will contribute volume growth and market share expansion. Recognising the need for advanced cooling solutions in rapidly expanding data centres, Castrol India is leveraging its expertise in fluid technology to innovate in this new domain. The company is focused on volume growth while maintaining margins and emphasising the premiumisation of products. "We expect Castrol's lubricants volume to increase by 4.5 per cent and 5 per cent in CY25E and CY26E, respectively. We recommend buying the stock with a target price of ₹ 239. At the current market price of ₹ 217, the stock trades at 19.5 times CY26E," said Vakil. Read all market-related news here Read more stories by Nishant Kumar Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions, as market conditions can change rapidly, and circumstances may vary.
Business Standard
29-04-2025
- Business
- Business Standard
PCBL Chemical consolidated net profit declines 9.98% in the March 2025 quarter
Sales rise 8.23% to Rs 2087.49 crore Net profit of PCBL Chemical declined 9.98% to Rs 100.16 crore in the quarter ended March 2025 as against Rs 111.26 crore during the previous quarter ended March 2024. Sales rose 8.23% to Rs 2087.49 crore in the quarter ended March 2025 as against Rs 1928.78 crore during the previous quarter ended March 2024. For the full year,net profit declined 11.48% to Rs 434.60 crore in the year ended March 2025 as against Rs 490.94 crore during the previous year ended March 2024. Sales rose 30.91% to Rs 8404.25 crore in the year ended March 2025 as against Rs 6419.77 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 2087.491928.78 8 8404.256419.77 31 OPM % 14.2616.05 - 15.9116.16 - PBDT 214.27224.52 -5 923.26893.59 3 PBT 126.13149.33 -16 577.58676.33 -15 NP 100.16111.26 -10 434.60490.94 -11
Business Standard
29-04-2025
- Business
- Business Standard
PCBL Chemical drops after Q4 PAT slumps 10% YoY to Rs 100 cr
PCBL Chemical fell 2.98% to Rs 371.75 after the company's consolidated net profit declined 9.7% to Rs 100.19 crore in Q4 FY25 as compared with Rs 110.95 crore in Q4 FY24. Revenue from operations dropped 8.23% to Rs 2,087.49 crore in Q4 FY25 as compared with Rs 1,928.78 crore in Q4 FY24. Profit before tax (PBT) slipped 15.54% YoY to Rs 126.13 crore in Q4 FY25. Net profit margin reduced to 4.85% in Q4 FY25 as against 5.78% in Q4 FY24. Total expenses increased 9.9% to Rs 1981.13 crore during the quarter as compared with Rs 1802.65 crore posted in same quarter last year. Cost of material consumed stood at Rs 1,453.60 crore (up 10.84% YoY), employee benefit expenses was at Rs 109.33 crore (up 34.93% YoY), finance cost was at Rs 103.16 crore (down 4.65% YoY) during the period under review. Revenue from Carbon black increased 1.3% to Rs 1667.44 crore in Q4 FY25 as against 1646.04 crore in Q4 FY24. The power business reported a revenue of Rs 74.19 crore, registering growth of 4.94% YoY. Notably, revenue from chemical segment jumped 56.87% YoY to Rs 375.02 crore in Q4 FY25. PCBL Chemical is a part of the RP-Sanjiv Goenka Group. It is Indias largest carbon black manufacturer, committed to sustainable growth. It also emphasizes performance materials and specialty chemicals, serving a diverse customer base in over 50 countries.
